Analgesics in Germany is set to demonstrate steady value growth in 2026, achieving EUR1,126 million, closely mirroring the moderate trajectory seen across Western Europe and reflecting a mature environment shaped by entrenched demand and persistent price competition. Attractiveness is defined by a combination of robust, recurring need and the rapid digitalisation of consumer behaviour. Success is increasingly determined by the ability to blend trusted efficacy with digital visibility, as established players like Haleon and Bayer Vital consolidate share through omnichannel strategies, while the rise of AI-powered personalisation and e-prescriptions reshapes the pain relief journey. Brands are best positioned for growth when they leverage digital platforms for targeted engagement, prioritise innovation around condition-specific solutions, and respond to evolving preferences for convenience, transparency, and self-management.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Germany with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Germany, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Germany report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Germany?
- Which are the leading brands in Analgesics in Germany?
- How are products distributed in Analgesics in Germany?
- How has the regulatory and operating environment for Analgesics changed in Germany?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Analgesics sees steady growth driven by digital pharmacy shift
Self-medication drives topical analgesics to lead German market
E-commerce and AI-driven personalisation reshape German analgesics
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Older adults projected to drive rising demand for targeted pain relief
Topical pain relief expected to lead growth as digital self-care grows
Online pharmacies to capture shoppers with convenience and digital trust
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Haleon sustains lead as Voltaren capitalises on self-medication trends
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain dominance as primary channel for analgesics
Omnichannel strategies reshape pain relief purchasing decisions
Retail e-commerce accelerates as fastest-growing channel for analgesics
Chart 1 Retail Channels 2021-2026
Non-pharmacy retail entry and digital recommendation engines drive innovation in analgesics
Redcare Pharmacy, dm-med and Voltaren lead recent innovation through digital platforms
Haleon's franchise strength and digital competition define the business impact of innovation
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!